Casual Conversations #19 Outside the USA

John Malanca hosts a discussion with Dr. Jordan Tishler, Dr. Adam Abodeely, Dr. Suraj Tandon, and Dr. Sandra Carrillo about medical cannabis regulations outside the United States, focusing on Colombia, Panama, Jamaica, and Canada.

Casual Conversations #18 Prescriptions

This episode of Casual Conversations, led by John Malanca of the Association of Cannabinoid Specialists, features Dr. Adam Abodeely, Dr. Suraj Tandon, and Dr. Jordan Tishler addressing the critical need for medical supervision in the use of cannabis as medicine.

Why We Need A More Medical-Oriented System for Cannabis

In this discussion, Dr. Jordan Tishler, a Harvard-educated physician with extensive experience in internal and emergency medicine, shares his insights and advocacy for a more medical-oriented cannabis system.

Cannabis Medicine and The Law

The webinar, sponsored by the Attorneys and Judges Council and hosted by Hadassah's Professional Councils Chair, Carol Greenfield, features Dr. Jordan Tishler discussing the medical use and legislative landscape of cannabis.

Questions Patients Ask (That Doctors Should Know How to Answer)

When considering medical cannabis, patients often have numerous questions for their physicians. These questions typically revolve around safety, efficacy, legal issues, and personal concerns. Here are some of the most common questions patients are likely to ask their physicians about medical cannabis:

ACS Comment to DEA Rescheduling Rule

The Association of Cannabinoid Specialists (ACS) is an international non-profit organization of physicians and other health professionals specializing in using cannabis or cannabinoids, as appropriate, for the care and treatment of patients suffering from a range of debilitating conditions such as cancer, Crohn’s disease, AIDS, multiple sclerosis, Parkinson’s disease, epilepsy, autism, and post-traumatic stress disorder, and patients with terminal illnesses.

Many Patients Using Cannabis Yet Medical Cannabis Systems Failing

State medical cannabis programs are slowly failing.  They are failing largely because they don’t support patient care, neither from the patients’ perspective nor from the practitioners’. 

If You’re Prescribing Opioids, Why Prescribe Not Cannabis First?

Don’t get me wrong. I am not part of the anti-opioid crowd. My only interest is in patient well-being which, of course, led me to practice cannabinoid medicine. I firmly believe that there are patients who need opioid medication. So the question really isn’t why are you prescribing opioids, but rather why aren’t you prescribing cannabinoids first.

Prescription Versus Recommendation of Medical Cannabis

Since the inception of medical cannabis legalization in California in 1996, physicians have only been able to write a “recommendation”. This was intended, at that time, to keep the practitioners out of trouble with the government by providing only a document stating that the benefits likely outweighed the risks. 

ACS and MSNJ Letter to Attorney General Merrick Garland

Dear Attorney General Garland:

Subsequent to the letter sent to you, and to Secretary Becerra, by Senators Warren and Booker dated October 6, 2021 requesting that you exercise your authority under the Controlled Substances Act of 1970 (CSA), we write to support their request and to support your pragmatic efforts to do so.